JP2009517366A5 - - Google Patents

Download PDF

Info

Publication number
JP2009517366A5
JP2009517366A5 JP2008541736A JP2008541736A JP2009517366A5 JP 2009517366 A5 JP2009517366 A5 JP 2009517366A5 JP 2008541736 A JP2008541736 A JP 2008541736A JP 2008541736 A JP2008541736 A JP 2008541736A JP 2009517366 A5 JP2009517366 A5 JP 2009517366A5
Authority
JP
Japan
Prior art keywords
tablet
bilayer
pharmaceutical
layer
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008541736A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009517366A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/068737 external-priority patent/WO2007060170A2/en
Publication of JP2009517366A publication Critical patent/JP2009517366A/ja
Publication of JP2009517366A5 publication Critical patent/JP2009517366A5/ja
Pending legal-status Critical Current

Links

JP2008541736A 2005-11-24 2006-11-22 テルミサルタン及び利尿剤を含有する二層錠剤 Pending JP2009517366A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05025601 2005-11-24
PCT/EP2006/068737 WO2007060170A2 (en) 2005-11-24 2006-11-22 Bilayer tablet comprising telmisartan and diuretic

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013023562A Division JP5833037B2 (ja) 2005-11-24 2013-02-08 テルミサルタン及び利尿剤を含有する二層錠剤

Publications (2)

Publication Number Publication Date
JP2009517366A JP2009517366A (ja) 2009-04-30
JP2009517366A5 true JP2009517366A5 (enExample) 2010-01-21

Family

ID=38067569

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008541736A Pending JP2009517366A (ja) 2005-11-24 2006-11-22 テルミサルタン及び利尿剤を含有する二層錠剤
JP2013023562A Active JP5833037B2 (ja) 2005-11-24 2013-02-08 テルミサルタン及び利尿剤を含有する二層錠剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013023562A Active JP5833037B2 (ja) 2005-11-24 2013-02-08 テルミサルタン及び利尿剤を含有する二層錠剤

Country Status (7)

Country Link
US (1) US8637078B2 (enExample)
EP (1) EP1959934A2 (enExample)
JP (2) JP2009517366A (enExample)
AR (1) AR057932A1 (enExample)
CA (1) CA2625404C (enExample)
TW (1) TW200806288A (enExample)
WO (1) WO2007060170A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8115011B2 (en) 2007-05-22 2012-02-14 Madrigal Pharmaceuticals, Inc. Diacylglycerol acyltransferase inhibitors
WO2009058950A2 (en) 2007-10-30 2009-05-07 Dr. Reddy's Laboratories Ltd. Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide
EP2252273B1 (en) 2008-03-19 2016-12-28 ratiopharm GmbH Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic
EP2291177A2 (en) 2008-05-05 2011-03-09 Farmaprojects, S.A. Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
CZ2008740A3 (cs) 2008-11-24 2010-01-06 Zentiva, A.S. Pevná farmaceutická kompozice s úcinnými látkami atorvastatinem a telmisartanem
WO2010146187A2 (en) 2009-06-19 2010-12-23 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of telmisartan
TR200906506A2 (tr) 2009-08-24 2011-03-21 Bi̇lgi̇ç Mahmut Telmisartan içeren katı dozaj formları.
JP2011136908A (ja) * 2009-12-25 2011-07-14 Kyowa Yakuhin Kogyo Kk アンギオテンシンｉｉ受容体拮抗剤を含む固形製剤および固形製剤におけるアンギオテンシンｉｉ受容体拮抗剤の保存安定性向上方法
WO2011161123A2 (en) 2010-06-21 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Multilayer pharmaceutical tablet comprising telmisartan and a diuretic
EP2851075B1 (en) * 2012-05-14 2021-12-01 Shionogi & Co., Ltd. Preparation containing 6,7-unsaturated-7-carbamoylmorphinan derivative
JP6018420B2 (ja) * 2012-06-05 2016-11-02 ニプロ株式会社 アンジオテンシンｉｉ受容体拮抗薬およびサイアザイド系利尿薬を含む医薬組成物
EP2952196A4 (en) * 2013-01-31 2016-08-03 Sawai Seiyaku Kk MULTILAYER TABLET WITH TELMISARTAN AND HYDROCHLOROTHIAZIDE
JP6218664B2 (ja) * 2013-04-04 2017-10-25 沢井製薬株式会社 テルミサルタン含有錠剤
CN108524460B (zh) * 2018-05-14 2021-01-01 佛山市南海东方澳龙制药有限公司 烯啶虫胺双层片

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6263520A (ja) * 1985-09-14 1987-03-20 Kyorin Pharmaceut Co Ltd 抗リウマチ剤
TW235239B (enExample) 1992-11-20 1994-12-01 Pfizer
AU676315B2 (en) * 1993-06-30 1997-03-06 Takeda Chemical Industries Ltd. Stabilized solid pharmaceutical preparation and method of producing the same
JP3220373B2 (ja) * 1995-11-28 2001-10-22 バイエル薬品株式会社 持続性ニフエジピン製剤
JPH1053520A (ja) * 1996-06-03 1998-02-24 Takeda Chem Ind Ltd 抗疲労剤
US5906852A (en) * 1997-11-04 1999-05-25 Nabisco, Inc. Surface-modified cellulose as low calorie flour replacements
WO2000027397A1 (en) 1998-11-06 2000-05-18 Glaxo Group Limited Antihypertensive medicaments containing lacidipine and telmisartan
FR2787330A1 (fr) 1998-12-18 2000-06-23 Sanofi Sa Composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et un immunosuppresseur pour la prevention ou le traitement des complications vasculaires du rejet de greffe
DE19901921C2 (de) 1999-01-19 2001-01-04 Boehringer Ingelheim Pharma Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels
EP1054019A1 (en) * 1999-05-18 2000-11-22 Shin-Etsu Chemical Co., Ltd. Low-substituted hydroxypropyl cellulose
EP1391200A4 (en) * 2001-05-25 2004-06-16 Ssp Co Ltd DRUG
ES2445041T3 (es) 2002-01-16 2014-02-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Método para la preparación de telmisartán amorfo
US20040028505A1 (en) 2002-06-07 2004-02-12 Bilbrey Robert A. Document tape binding system with automatic tape feed, tape indicia sensing, spine printing method and post-bind automation mechanisms
DE10244681A1 (de) * 2002-09-24 2004-04-08 Boehringer Ingelheim International Gmbh Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung
US8980870B2 (en) * 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
DE10319450A1 (de) 2003-04-30 2004-11-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung des Telmisartan Natriumsalzes
WO2005014043A1 (en) 2003-07-16 2005-02-17 Boehringer Ingelheim International Gmbh Chlorthalidone combinations
DE102004008804A1 (de) * 2004-02-20 2005-09-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mehrschichttablette
CA2589493A1 (en) 2004-12-17 2006-06-22 Boehringer Ingelheim International Gmbh Combination therapy comprising telmisartan and hydrochlorothiazide
AU2005338461A1 (en) * 2005-11-22 2007-05-31 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions of telmisartan

Similar Documents

Publication Publication Date Title
JP2009517366A5 (enExample)
JP5110697B2 (ja) 固形製剤
US20090186086A1 (en) Solid multilayer oral dosage forms
JP2008501025A5 (enExample)
JP2007506774A5 (enExample)
JP2005508331A5 (enExample)
ES2282062T1 (es) Composicion farmaceutica que contiene irbesartan.
TW201424772A (zh) 經口投與用醫藥組成物
TW201202249A (en) Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
JP2012506911A5 (enExample)
CA2540047A1 (en) Oros push-stick for controlled delivery of active agents
AU2009269875A1 (en) Controlled release treatment of depression
JP2005506987A5 (enExample)
CA2858522A1 (en) Methods for treating cardiovascular disorder
JP2016518398A (ja) 低用量医薬組成物
AR061790A1 (es) Composicion farmaceutica solida para la administracion oral, formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina, y su uso en la manufactura de un medicamento
JP2009504727A (ja) メトホルミン徐放性錠剤およびその製造方法
WO2015053227A1 (ja) 口腔内崩壊錠
US8637078B2 (en) Bilayer tablet comprising telmisartan and diuretic
KR101512386B1 (ko) 미티글리나이드 및 메트포르민 복합제제 및 그의 제조방법
JP6758488B2 (ja) カンデサルタンおよびアムロジピンを含む単一層からなる複合製剤
HK1204562A1 (en) Oral formulation for the treatment of cardiovascular diseases
TW200812645A (en) Tetracycline package formulations
TW201201800A (en) A pharmaceutical controlled release composition of losartan
EP2438911A1 (en) Pharmaceuticals compositions comprising sulphonylurea-class insulin secretagogue and polyethylene glycol castor oil